Extracorporeal circulation can induce hypotension by both blood-material contact and pump-induced platelet aggregation

Journal of Thoracic and Cardiovascular Surgery

Volumn 120, Issue 1, 2000, Pages 12-19

  Borgdorff, Piet ^a   Van den Bos, Gerard ^a   Tangelder, Geert Jan ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AURINTRICARBOXYLIC ACID; BIOMATERIAL;

ANIMAL MODEL; ANIMAL TISSUE; AORTA PRESSURE; AORTOFEMORAL BYPASS; ARTERY RESISTANCE; ARTICLE; BLOOD; BLOOD PUMP; CONTROLLED STUDY; EXTRACORPOREAL CIRCULATION; FEMORAL ARTERY; HYPOTENSION; LUNG EDEMA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SHEAR STRESS; THROMBOCYTE AGGREGATION; VASODILATATION;

EID: 0034235675     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1067/mtc.2000.105454     Document Type: Article

References (26)

1. Christakis G.T., Fremes S.E., Koch J.P. Determinants of low systemic vascular resistance during cardiopulmonary bypass. Ann Thorac Surg. 58:1994;1040-1049.
2. Butler J., Rocker G.M., Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg. 55:1993;552-559.
3. Carretta R., Fabris B., Fischetti F. Peripheral adrenoceptors in hypotension of hemodialyzed uremic patients. Nephron. 62:1992;429-433.
4. Maeda K., Shinzato T., Nakai S., Takai I., Kobayakawa H. Mechanism of dialysis-induced hypotension. Nagoya J Med Sci. 54:1992;1-10.
5. Sakurai H., Maeda M., Murase M., Koyama T., Hayakawa M. Hemofiltration removes bradykinin generated in the priming blood in cardiopulmonary bypass during circulation. Ann Thorac Cardiovasc Surg. 4:1998;59-63.
6. Downing S.W., Edmunds L.H. Release of vasoactive substances during cardiopulmonary bypass. Ann Thorac Surg. 54:1992;1236-1243.
7. Mylecharane E.J. Mechanisms involved in serotonin-induced vasodilatation. Blood Vessels. 27:1990;116-126.
8. Aldea G.S., Lilly K., Gaudiani J.M. Heparin-bonded circuits improve clinical outcomes in emergency coronary artery bypass grafting. J Card Surg. 12:1997;389-397.
9. Gu, YJ, van Oeveren, W, Akkerman, C, Boonstra, PW, Huyzen, RJ, Wildevuur, CR1993Heparin-coated circuits reduce the inflammatory response to cardiopulmonary bypass.Ann Thorac Surg.
10. te Velthuis H., Baufreton C., Jansen P.G. Heparin coating of extracorporeal circuits inhibits contact activation during cardiac operations. J Thorac Cardiovasc Surg. 114:1997;117-122.
11. Olsson P., Lagergren H., Larsson R., Radegran K. Prevention of platelet adhesion and aggregation by a glutardialdehyde-stabilized heparin surface. Thromb Haemost. 37:1977;274-282.
12. Muehrcke D.D., McCarthy P.M., Marchant K. Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial. J Thorac Cardiovasc Surg. 112:1996;472-483.
13. Palatianos G.M., Dewanjee M.K., Kapadvanjwala M., Novak S., Sfakianakis G.N., Kaiser G.A. Cardiopulmonary bypass with a surface-heparinized extracorporeal perfusion system. ASAIO Trans. 36:1990;M476-9.
14. Borgdorff P., van den Berg R.H., Vis M.A., van den Bos G.C., Tangelder G.J. Pump-induced platelet aggregation in albumin-coated extracorporeal systems. J Thorac Cardiovasc Surg. 118:1999;946-952.
15. Mulvihill J.N., Faradji A., Oberling F., Cazenave J.P. Surface passivation by human albumin of plasmapheresis circuits reduces platelet accumulation and thrombus formation: experimental and clinical studies. J Biomed Mater Res. 24:1990;155-163.
16. Borgdorff P., Kok W.E.M., van den Bos G.C. Extracorporeal circuits and autoregulation: effect of albumin coating. Am J Physiol. 263:1992;H1397-401.
17. Borgdorff P., Kok W.E., Vis M.A., van den Bos G.C. Vasodilation by shear-induced platelet aggregation in extracorporeal circuits. Am J Physiol. 266:1994;H891-7.
18. Komoda T., Maeta H., Imawaki S. A pulsatile cardiopulmonary bypass system that prevents negative pressure at the membrane oxygenator. ASAIO J. 39:1993;936-941.
19. Murakami F., Usui A., Hiroura M., Kawamura M., Koyama T., Murase M. Clinical study of totally roller pumpless cardiopulmonary bypass system. Artif Organs. 21:1997;803-807.
20. Borgdorff P., Sipkema P., Westerhof N. Pump perfusion abolishes autoregulation possibly via prostaglandin release. Am J Physiol. 255:1988;H280-7.
21. Alevriadou B.R., Moake J.L., Turner N.A. Real-time analysis of shear-dependent thrombus formation and its blockade by inhibitors of von Willebrand factor binding to platelets. Blood. 81:1993;1263-1276.
22. Moake J.L., Turner N.A., Stathopoulos N.A., Nolasco L., Hellums J.D. Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin. Blood. 71:1988;1366-1374.
23. Phillips M.D., Moake J.L., Nolasco L., Turner N. Aurin tricarboxylic acid: a novel inhibitor of the association of von Willebrand factor and platelets. Blood. 72:1988;1898-1903.
24. Sixma J.J., Ijsseldijk M.J., Hindriks G. Adhesion of blood platelets is inhibited by VCL, a recombinant fragment (leucine504 to lysine728) of von Willebrand factor. Arterioscler Thromb Vasc Biol. 16:1996;64-71.
25. Acland R.D., Anderson G., Siemionow M., McCabe S. Direct in vivo observations of embolic events in the microcirculation distal to a small-vessel anastomosis. Plast Reconstr Surg. 84:1989;280-288.
26. Fujimoto T., Suzuki H., Tanoue K., Fukushima Y., Yamazaki H. Cerebrovascular injuries induced by activation of platelets in vivo. Stroke. 16:1985;245-250.